Fennec Pharmaceuticals (FENC) Common Equity (2010 - 2025)
Fennec Pharmaceuticals (FENC) posted Common Equity of $35.5 million for Q4 2025, up 889.67% on a QoQ basis from -$4.5 million in Q3 2025, and up 704.09% year-over-year from $4.4 million in Q4 2024.
Fennec Pharmaceuticals (FENC) Common Equity (2010 - 2025) Analysis & Trends
Fennec Pharmaceuticals' Common Equity history runs 16 years deep, the most recent figure standing at $35.5 million for Q4 2025.
- Quarterly Common Equity rose 704.09% year-over-year to $35.5 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $35.5 million (up 704.09% YoY) and the FY2025 annual result came in at $35.5 million, up 704.09% from the prior year.
- Common Equity was $35.5 million for Q4 2025 at Fennec Pharmaceuticals, up from -$4.5 million in the prior quarter.
- Across five years, Common Equity topped out at $35.5 million in Q4 2025 and bottomed at -$11.6 million in Q4 2023.
- A 5-year average of $3.6 million and a median of -$2.0 million in 2022 frame the typical range for Common Equity.
- Annual changes were most pronounced in 2023 — Common Equity slumped 475.84% — and 2025, when it surged 704.09%.
- Fennec Pharmaceuticals' Common Equity stood at $15.8 million in 2021, then sank by 116.29% to -$2.6 million in 2022, then tumbled by 352.39% to -$11.6 million in 2023, then soared by 49.48% to -$5.9 million in 2024, then jumped by 704.09% to $35.5 million in 2025.
- Business Quant data shows FENC's Common Equity at $35.5 million in Q4 2025, -$4.5 million in Q3 2025, and -$7.5 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 251.12 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | -98.34 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 4.76 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 32.36 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 19.36 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 31.42 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 795.79 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 1.50 Bn |
| 10 | Fennec Pharmaceuticals | 346.75 Mn | 309.97 Mn | 12.01 Mn | 35.47 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 35.47 Mn |
| Sep 30, 2025 | -4.49 Mn |
| Jun 30, 2025 | -7.46 Mn |
| Mar 31, 2025 | -5.88 Mn |
| Dec 31, 2024 | -5.87 Mn |
| Sep 30, 2024 | -5.17 Mn |
| Jun 30, 2024 | -1.36 Mn |
| Mar 31, 2024 | 3.01 Mn |
| Dec 31, 2023 | -11.62 Mn |
| Sep 30, 2023 | -10.53 Mn |
| Jun 30, 2023 | -9.73 Mn |
| Mar 31, 2023 | -7.34 Mn |
| Dec 31, 2022 | -2.57 Mn |
| Sep 30, 2022 | 2.80 Mn |
| Jun 30, 2022 | 8.54 Mn |
| Mar 31, 2022 | 12.52 Mn |
| Dec 31, 2021 | 15.77 Mn |
| Sep 30, 2021 | 19.01 Mn |
| Jun 30, 2021 | 22.28 Mn |
| Mar 31, 2021 | 24.93 Mn |